looks like we're slowly bleeding back to $9. I hate to sell but gotta protect my portfolio.
well, then it is a "risk off market" perhaps due to Cyprus. if all biotechs are sliding it is not CLDX centric.
And Paul, when did you buy you shares, and at what price?
$9.20 a few weeks ago.